APLISOL Drug Profile

Summary for Tradename: APLISOL

Patents:	0
Applicants:	1
BLAs:	1
Drug Prices:	Drug price information for APLISOL

See drug prices for APLISOL

Pharmacology for APLISOL

Physiological Effect	Cell-mediated Immunity
Established Pharmacologic Class	Skin Test Antigen Tuberculosis Skin Test
Chemical Structure	Antigens, Bacterial

Note on Biologic Patents

Matching patents to biologic drugs is far more complicated than for small-molecule drugs.

DrugPatentWatch employs three methods to identify biologic patents:

1. Brand-side disclosures in response to biosimilar applications

These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.

2. General brand-side disclosures

These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

3. Patents from broad patent text search

For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

1) High Certainty: US Patents for APLISOL Derived from Brand-Side Litigation

No patents found based on brand-side litigation

2) High Certainty: US Patents for APLISOL Derived from Company Disclosures

No patents found based on company disclosures

3) Low Certainty: US Patents for APLISOL Derived from Patent Text Search

These patents were obtained by searching patent claims

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Patent No.	Estimated Patent Expiration	Source
Par Pharmaceutical Companies, Inc.	APLISOL	tuberculin, purified protein derivative	Injection	103782		2011-08-02	Patent claims search
Par Pharmaceutical Companies, Inc.	APLISOL	tuberculin, purified protein derivative	Injection	103782		2006-03-06	Patent claims search
Par Pharmaceutical Companies, Inc.	APLISOL	tuberculin, purified protein derivative	Injection	103782		2015-11-27	Patent claims search
Par Pharmaceutical Companies, Inc.	APLISOL	tuberculin, purified protein derivative	Injection	103782		2040-01-28	Patent claims search
Par Pharmaceutical Companies, Inc.	APLISOL	tuberculin, purified protein derivative	Injection	103782		2027-04-17	Patent claims search